Mitochondrial membrane potential and nucleosidic inhibitors of HIV reverse transcriptase: a cytometric approach

被引：11

作者：

Ferraresi, R

Troiano, L

Rossi, D

Gualdi, E

Lugli, E

Mussini, C

Cossarizza, A

机构：

[1] Univ Modena & Reggio Emilia, Sch Med, Dept Biomed Sci, Chair Immunol,Sect Gen Pathol, I-41100 Modena, Italy

[2] Univ Hosp, Azienda Policlin, Infect Dis Clin, Modena, Italy

来源：

MITOCHONDRION | 2004年 / 4卷 / 2-3期

关键词：

mitochondria; HAART; flow cytometry;

D O I：

10.1016/j.mito.2004.05.015

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Mitochondrial toxicity is a relevant side effect of anti-HIV antiretroviral therapy. Adequate experimental models and advanced technologies are crucial to investigate properly mitochondrial toxicity. Functional flow cytometry allows a rapid and sensitive evaluation of several parameters on single cells, and is an excellent tool to investigate the impact of antiviral drug on mitochondrial activity. We used such approach to analyze in vitro mitochondrial toxicity induced by stavudine and zidovudine on cell lines of different origin (hemopoietic: A301, U937, CEM, K562; hepatic: HepG2), and found that the cell lines had a different sensitivity to the action of the drugs. (C) 2004 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

引用

页码：271 / 278

页数：8

共 50 条

[31] Searching for Novel HIV-1 Reverse Transcriptase Inhibitors: a Relaxed Complex Approach
Ivetac, Anthony
McCammon, J. Andrew
BIOPHYSICAL JOURNAL, 2010, 98 (03) : 460A - 460A
[32] Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders
Hung, Kui-Ming
Chen, Pei-Chun
Hsieh, Han-Chieh
Calkins, Marcus J.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2017, 1863 (02): : 406 - 413
[33] Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy
Lewis, W
ANTIVIRAL THERAPY, 2005, 10 : M13 - M27
[34] Forensic mitochondrial DNA analysis in HIV-infected patients treated with nucleoside reverse transcriptase inhibitors
Robino, C.
Colla, C.
Biglino, A.
Degioanni, M.
Gino, S.
Torre, C.
FORENSIC SCIENCE INTERNATIONAL GENETICS SUPPLEMENT SERIES, 2009, 2 (01) : 501 - 502
[35] Naringin Ameliorates HIV-1 Nucleoside Reverse Transcriptase Inhibitors-Induced Mitochondrial Toxicity
Oluwafeyisetan, Adebiyi
Olubunmi, Adebiyi
Peter, Owira
CURRENT HIV RESEARCH, 2016, 14 (06) : 506 - 516
[36] Pyridazines 92. Synthesis of dialkyldipyridazinodiazepinones as potential HIV-1 reverse transcriptase inhibitors
Heinisch, G
Matuszczak, B
Spielmann, E
Witvrouw, M
Pannecouque, C
De Clercq, E
JOURNAL OF HETEROCYCLIC CHEMISTRY, 2001, 38 (01) : 125 - 130
[37] Emerging reverse transcriptase inhibitors for HIV-1 infection
Rai, Mohammad A.
Pannek, Sam
Fichtenbaum, Carl J.
EXPERT OPINION ON EMERGING DRUGS, 2018, 23 (02) : 149 - 157
[38] ALPHA-OLIGODEOXYNUCLEOTIDES AS INHIBITORS OF HIV REVERSE-TRANSCRIPTASE
PAUWELS, R
DEBYSER, Z
BALZARINI, J
BABA, M
DESMYTER, J
RAYNER, B
MORVAN, F
IMBACH, JL
DE CLERCQ, E
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 1989, 8 (5-6): : 995 - 1000
[39] HIV-1 reverse transcriptase resistance to nonnucleoside inhibitors
Spence, RA
Anderson, KS
Johnson, KA
BIOCHEMISTRY, 1996, 35 (03) : 1054 - 1063
[40] New pyrophosphate analogues as substrates and inhibitors of HIV reverse transcriptase
Kukhanova, MK
Zakirova, NF
Ivanov, AV
Yasko, MV
Skoblov, YS
Khomutov, AR
ANTIVIRAL RESEARCH, 2003, 57 (03) : A47 - A47

← 1 2 3 4 5 →